AIC
CLPT icon

AWM Investment Company’s ClearPoint Neuro CLPT Stock Holding History

AWM Investment Company’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-131,431
Closed -$894K – 101
2024
Q1 		$894K Buy
+131,431
New +$919K 0.12% 94

Other funds holding CLPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CWM
Cahill Wealth Management Portage, Michigan $196M AUM 8.5% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

AWM Investment Company's CLPT Position: Q2 2024 in Review

AWM Investment Company sold out of ClearPoint Neuro (CLPT) in Q2 2024, closing a stake of 131,431 shares — an estimated $894K sold.

AWM Investment Company first reported a position in CLPT in Q1 2024 and held it in 1 quarter. The position peaked at $894K in Q1 2024. 86 funds tracked by Wall St. Rank hold CLPT as of Q2 2024.

  • AWM Investment Company reported no remaining ClearPoint Neuro position as of Q2 2024 after selling out during the quarter.
  • AWM Investment Company sold 131,431 ClearPoint Neuro shares in Q2 2024, an estimated $894K.
  • AWM Investment Company first reported a position in ClearPoint Neuro in Q1 2024 and held it in 1 quarter.
  • AWM Investment Company's ClearPoint Neuro position peaked at $894K in Q1 2024.
  • 86 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2024.

Based on AWM Investment Company's 13F filing for Q2 2024, filed 14 Aug 2024.